Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Kevin J. Cullen(University of Maryland, Baltimore), Nicholas J. Sarlis(Incyte (United States)), Marietta Tan(University of Maryland, Baltimore), Jochen H. Lorch(Northwestern University), Lisa M. Schumaker, Robert I. Haddad(Georgetown University), Olga Goloubeva(University of Maryland, Baltimore)
Cited by 487
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926